N Danchin Selected Research

N Danchin Research Topics

Disease

17	Myocardial Infarction 06/2020 - 12/2000
13	Acute Coronary Syndrome 04/2013 - 11/2001
9	Coronary Artery Disease (Coronary Atherosclerosis) 02/2018 - 01/2000
7	Hypertension (High Blood Pressure) 01/2022 - 08/2005
7	Heart Failure 04/2014 - 01/2002
6	Unstable Angina 12/2010 - 05/2000
4	Infarction (Infarctions) 06/2020 - 03/2000
4	Left Ventricular Dysfunction 06/2007 - 03/2000
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2012
3	ST Elevation Myocardial Infarction 06/2020 - 12/2004
3	Non-ST Elevated Myocardial Infarction 12/2016 - 12/2000
2	Dyslipidemias (Dyslipidemia) 02/2018 - 11/2004
2	Hemorrhage 04/2013 - 08/2006
2	Ischemia 12/2007 - 12/2000
2	Coronary Disease (Coronary Heart Disease) 11/2004 - 07/2001
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2003 - 11/2000
2	Thrombosis (Thrombus) 06/2003 - 05/2001
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2001 - 12/2000
2	Coronary Thrombosis 05/2001 - 11/2000
2	Pathologic Constriction (Stenosis) 05/2001 - 11/2000
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Xanthomatosis (Xanthoma) 02/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2018
1	Gout 05/2015
1	Overweight 04/2011
1	Obesity 04/2011
1	Ecchymosis 04/2010
1	Ventricular Dysfunction 06/2007
1	Stable Angina 06/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2006
1	Renal Insufficiency (Renal Failure) 09/2005
1	Hyperglycemia 08/2005
1	Fever (Fevers) 06/2004
1	Endocarditis 06/2004
1	Pulmonary Hypertension 12/2002
1	Hypoxia (Hypoxemia) 12/2002
1	Familial Primary Pulmonary Hypertension 12/2002

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014 - 11/2001
3	LipidsIBA 01/2022 - 07/2001
3	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2004
3	CholesterolIBA 01/2022 - 11/2001
3	bivalirudin (Angiomax)FDA Link 04/2013 - 12/2007
3	Glycoproteins (Glycoprotein)IBA 08/2006 - 11/2001
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2005 - 12/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2003 - 05/2000
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2000
2	C-Reactive ProteinIBA 06/2020 - 09/2002
2	ElementsIBA 02/2018 - 06/2017
2	Insulin (Novolin)FDA Link 02/2016 - 10/2012
2	Platelet Membrane Glycoprotein IIbIBA 04/2013 - 12/2007
2	AnticoagulantsIBA 04/2013 - 08/2006
2	omega-Chloroacetophenone (Mace)IBA 10/2011 - 06/2003
2	Clopidogrel (Plavix)FDA Link 10/2011 - 06/2003
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2011 - 01/2004
2	LDL CholesterolIBA 02/2011 - 11/2004
2	HomocysteineIBA 06/2007 - 01/2000
2	CreatinineIBA 01/2007 - 08/2006
2	Heparin (Liquaemin)FDA LinkGeneric 08/2006 - 12/2000
2	Blood Glucose (Blood Sugar)IBA 07/2006 - 08/2005
2	Ticlopidine (Ticlid)FDA LinkGeneric 06/2003 - 05/2000
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2002 - 07/2001
2	Complement System Proteins (Complement)IBA 01/2002 - 05/2001
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2000 - 11/2000
1	HDL LipoproteinsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	PTX3 proteinIBA 06/2020
1	Interleukin-6 (Interleukin 6)IBA 06/2020
1	Troponin IIBA 06/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2018
1	A-factor (Streptomyces)IBA 02/2018
1	AntibodiesIBA 12/2016
1	Colchicine FDA LinkGeneric 05/2015
1	Allopurinol (Remid)FDA LinkGeneric 05/2015
1	Xanthine OxidaseIBA 05/2015
1	Cytochrome P-450 CYP2C19IBA 10/2011
1	Aryldialkylphosphatase (Paraoxonase)IBA 10/2011
1	paragonIBA 12/2007
1	TroponinIBA 12/2007
1	Biomarkers (Surrogate Marker)IBA 06/2007
1	DiureticsIBA 01/2007
1	Biological ProductsIBA 11/2006
1	Coenzyme A (CoA)IBA 08/2006
1	Vitamin K FDA Link 09/2005
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2004
1	Chewing Gum (Chewing Gums)IBA 06/2004
1	thienopyridineIBA 06/2003
1	Sildenafil Citrate (Viagra)FDA Link 12/2002
1	Iloprost (Ventavis)FDA Link 12/2002
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2002

Therapy/Procedure

11	Therapeutics 02/2016 - 12/2000
9	Percutaneous Coronary Intervention 06/2020 - 11/2001
5	Stents 06/2003 - 03/2000
4	Secondary Prevention 11/2014 - 08/2002
1	Drug Therapy (Chemotherapy) 04/2014
1	Length of Stay 12/2010
1	Antibiotic Prophylaxis 06/2004
1	Premedication 06/2003